2019
DOI: 10.1016/j.medcle.2019.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Bacteraemia by Micrococcus luteus in an inmunocompromised patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 5 publications
0
5
1
Order By: Relevance
“…invasive infections (Laupland et al 2019;Martín Guerra et al 2019;Neff et al 2020;Zhu et al 2021). Contrary to our findings, other studies showed a much lower percentage of contamination with bacilli, micrococci, and streptococci on the surfaces of stethoscopes.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…invasive infections (Laupland et al 2019;Martín Guerra et al 2019;Neff et al 2020;Zhu et al 2021). Contrary to our findings, other studies showed a much lower percentage of contamination with bacilli, micrococci, and streptococci on the surfaces of stethoscopes.…”
Section: Discussioncontrasting
confidence: 99%
“…For most people, these bacteria are not etiologic agents of infections. However, for children, immunosuppressed patients, or patients undergoing invasive medical procedures during hospitalization, micrococci, and streptococci can cause severe invasive infections ( Laupland et al 2019 ; Martín Guerra et al 2019 ; Neff et al 2020 ; Zhu et al 2021 ). Contrary to our findings, other studies showed a much lower percentage of contamination with bacilli, micrococci, and streptococci on the surfaces of stethoscopes.…”
Section: Discussionmentioning
confidence: 99%
“…It has been noted to be an opportunistic bacterium and immunocompromised patients pose the greatest risk of infection 20,21 . Treatment of M. luteus infection typically involves the use of antibiotics such as penicillin, vancomycin and gentamicin 22 . Cefoxitin has also been successfully used to treat peritonitis as a result of M. luteus infection 23 .…”
Section: Resultsmentioning
confidence: 99%
“…Ovipin peptide was inhibited the growth of Micrococcus luteus A270 (MIC = 1,94 µM (2,84 µg/mL)), Aspergillus niger (MIC = 31,01 µM (45,5 µg/mL)) and this peptide not was able inhibited the growth of E. coli. M. luteus in general it is founded in skin, mucous membranes and oropharynx, but in immunosuppressed patients this microorganism can triggered bacteremia infection (Martín Guerra et al, 2019). Invasive aspergillosis is also problem serious for a medicine because affect mainly immunocomppromissed individuals or patients which receive immunosuppressive treatments, as also solid organ transplantation (Sugui et al, 2014).…”
Section: Discussionmentioning
confidence: 99%